News Center

Clear filters

Edward Zartler Ph.D Joins the US Biologics Team at SGS

Edward R. Zartler, Ph.D has been appointed as Director of Biopharmaceutical Services at SGS in the US.

SGS Experts Included in Medicine Maker's 2020 Power List

The list celebrates individuals who’ve had a positive impact on the pharmaceutical industry over the last 12 months.

SGS Joins Oxford University Consortium to Develop COVID-19 Vaccine

SGS's Center of Excellence for biosafety is collaborating with other leading UK experts to develop a vaccine against COVID-19 coronavirus.

COVID-19 INTEL – an AI Platform for Medical Researchers Launches

As medical research teams accelerate their efforts to combat the COVID-19 pandemic, SGS Digicomply has launched a complimentary, new AI tool to facilitate and enhance their work.

Local Team Donates PPE and Offers Beds & Staff to ZNA Stuivenberg Hospital, Antwerp, Belgium

As pressure increases on hospitals to treat more COVID-19 patients, SGS offers support from its Clinical Pharmacology Unit (CPU).

GMP Compliant Vaccine Testing Solution for Coronavirus

We believe that our Center of Excellence for biosafety can help contribute to the fight against coronavirus.

Vote for SGS in the 2020 Vaccine Industry Excellence Awards

Nominated by partners and stakeholders around the globe, SGS hopes to win this year’s Best Contract Research Organization at the ViE Awards.

JRS Pharma Gains EXCiPACT Certification From SGS

SGS awards EXCiPACT certification to JRS Pharma, demonstrating its compliance as a pharmaceutical excipient supplier.